In this edition:
rs10191329 & brain atrophy
MS-related brain tissue loss before clinical onset
COVID-19 & MS disease course
Relapses before, during & after pregnancy with ocrelizumab
EBV & MS
Predictors of a relapsing course of MOGAD
MOG-IgA as a diagnostic biomarker
Epigenetics & environmental factors in MS
Fenebrutinib in relapsing MS
Neurofilament light chain, GFAP & Contactin-1 in progressive MS
Please login below to download this issue (PDF)